Isis Pharmaceuticals

Isis Pharmaceuticals Making Antisense

Isis Pharmaceuticals Making Antisense

Seeking Alpha

When It Comes To Biotech, Diversity Is Key

When It Comes To Biotech, Diversity Is Key

Seeking Alpha

Xenon licenses antisense drug SEN701 from Isis Pharmaceuticals

Xenon licenses antisense drug SEN701 from Isis Pharmaceuticals

Yahoo/Fly on the Wall

Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca

Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca

Yahoo

Isis Pharmaceuticals initiates clinical study of ISIS-SMN Rx in infants with SMA

Isis Pharmaceuticals initiates clinical study of ISIS-SMN Rx in infants with SMA

Yahoo/Fly on the Wall

Isis Pharmaceuticals - Antisense Making Sense

Isis Pharmaceuticals - Antisense Making Sense

Seeking Alpha

Is RNA Drug Development Coming of Age?

Is RNA Drug Development Coming of Age?

Motley Fool

Isis: Big Pharma's Little Friend

Isis: Big Pharma's Little Friend

Motley Fool

Roche to use Isis's technology to develop brain disorder drug

Roche to use Isis's technology to develop brain disorder drug

Reuters

Isis Publishes Encouraging Data

Isis Publishes Encouraging Data

Yahoo/Zacks